Yield10 Bioscience
YTEN
EPS for Yield10 Bioscience (YTEN)
EPS in 2023 (TTM): -$2.78
According to Yield10 Bioscience's latest financial reports the company's current EPS (TTM) is -$2.78. In 2022 the company made an earnings per share (EPS) of -$2.76 a decrease over its 2021 EPS that were of -$2.34.
EPS history for Yield10 Bioscience from 2004 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.78 | 0.72% |
| 2022 | -$2.76 | 17.95% |
| 2021 | -$2.34 | -50.21% |
| 2020 | -$4.70 | -85.74% |
| 2019 | -$32.95 | -11.42% |
| 2018 | -$37.20 | -71.65% |
| 2017 | -$131.20 | 16.73% |
| 2016 | -$112.40 | -70.73% |
| 2015 | -$384.00 | -74.47% |
| 2014 | -$1,504 | -29.59% |
| 2013 | -$2,136 | -990% |
| 2012 | $240.00 | -108% |
| 2011 | -$3,000 | -13.79% |
| 2010 | -$3,480 | -10.49% |
| 2009 | -$3,888 | 3.18% |
| 2008 | -$3,768 | 24.6% |
| 2007 | -$3,024 | -60.92% |
| 2006 | -$7,739 | 25.95% |
| 2005 | -$6,144 | 86.86% |
| 2004 | -$3,288 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$0.06000 | -97.84% | Bahamas |
 NRC Health
NRC | $1.19 | -142.81% | 🇺🇸 USA |